The Fading Art of Preserving the Dead
The New York Times
A dwindling group of professionals is tasked with navigating the often fraught passage from life to death.
More Related News
Lawmakers raising national security concerns and seeking to disconnect a major Chinese firm from U.S. pharmaceutical interests have rattled the biotech industry. The firm is deeply involved in development and manufacturing of crucial therapies for cancer, cystic fibrosis, H.I.V. and other illnesses.